US health officials reviewing huge COVID vaccine change ahead of fresh…

The U.S. Food ‌and Drug Administration is set to focus on which variants the up to date COVID-19 vaccine will goal. Advisers are deciding which of the latest subvariants, NB.1.8.1 or XFG, the 2027-27 vaccine will goal. The World Health Organization notes that the new variants emerged last yr.

Recently, the WHO urged vaccine producers to goal the monvarient LP.8.1 pressure over other circulating variants, such ​as XFG or NB.1.8.1.

The FDA has not yet determined which route to take ahead of a scheduled assembly on Thursday. It marks the first discussions of COVID vaccines after the departure of Commissioner Marty Makary. His substitute, Deputy Commissioner for Food Kyle Diamantas, assumed Makary’s duties on May 12.

Makary drew criticism for ​his clashes with drugmakers for questioning reviews of varied medication and vaccines. Amid the shakeup at the FDA in the wake of Makary’s tenure, Karim Mikhail was named the performing director of the FDA’s vaccines and biologics unit.

For the 2025-26 season, the FDA advisable that COVID pictures goal LP.8.1, a subvariant of the JN.1 pressure. U.S. Centers for Disease Control and ​Prevention experiences confirmed ​the XFG subvariant was ⁠estimated to account for the bulk of instances in the United States.

Vaccine producers Moderna, Pfizer-BioNTech, and Novavax shared that they’re prepared to produce an XFG vaccine for the 2026-27 vaccination season, ​the FDA experiences.

How many people have died from COVID?

Using info gathered from 231 international locations, the WHO experiences that 7,114,938 have died from COVID since it started gathering data in January 2020.

How many Americans are getting vaccinated?

According to the CDC, “9.7% of children were reported to be up to date with the 2025-26 COVID-19 vaccine” and as of February 22, 2026, “17.5% of adults reported having received the 2025-26 COVID-19 vaccine.”